If you are reading this for someone you love, the fear is rational; the stakes really are this high. Fentanyl is now the leading cause of drug overdose death in the United States, responsible for more than two-thirds of all overdose fatalities according to the Centers for Disease Control and Prevention.
A synthetic opioid 50 to 100 times more potent than morphine by weight, illicitly manufactured fentanyl has infiltrated virtually every segment of the street drug supply, appearing in counterfeit prescription pills, heroin, cocaine, and methamphetamine.
The Virginia Department of Health Office of the Chief Medical Examiner has documented substantial fentanyl involvement in drug overdose deaths across the state, with the Roanoke region’s emergency department visit rate for nonfatal overdoses running two times higher than the rest of Virginia for more than a decade along the I-81 and I-581 corridors (VDH, 2024).
Fentanyl use disorder is treatable. The clinical realities are different from prior generations of opioid addiction in important ways, and treatment that addresses fentanyl specifically has to account for the potency, the post-acute withdrawal timeline, and the elevated overdose risk in early recovery. Our treatment approach is built around those realities, and the level-of-care recommendation is made during the admissions assessment using an ASAM level-of-care assessment.
Why Fentanyl Is Uniquely Dangerous
Fentanyl is in nearly everything now. That is the working assumption our clinical team has been operating under for years, and the regional data backs it up. The Roanoke Valley drug supply is contaminated, and most overdoses we see clinically involve fentanyl whether the person knew they were taking it or not. Here is the short version of why this substance is different.
Extreme potency
A dose invisible to the naked eye can be fatal. The therapeutic window between an effective and a lethal dose is extraordinarily narrow.
Rapid onset
Effects peak faster than many other opioids, which means an overdose can occur before a person realizes they have taken too much.
Shorter duration
Faster offset drives more frequent dosing and increases total exposure across a day.
Inconsistent distribution
Fentanyl is often mixed unevenly into other substances, creating hot spots that make dose prediction impossible even for experienced users.
May require multiple naloxone doses
High-potency fentanyl overdoses may not reverse fully with a single standard naloxone dose. Additional doses should be administered and emergency services called.
Fentanyl Dependence and Withdrawal
The withdrawal window is shorter and sharper than people expect, and we want families to understand the timeline before it starts. Physical dependence on fentanyl follows the same basic opioid withdrawal pattern as heroin and other opioids, but fentanyl’s shorter half-life means withdrawal onset can occur within hours of the last use. Medically supervised detox with buprenorphine, or in some cases methadone at a licensed Opioid Treatment Program, is strongly recommended before transitioning to our outpatient programs. Detox happens with our partner providers in the Roanoke Valley, coordinated by our admissions team.
Clinical Considerations Specific to Fentanyl
Post-Acute Withdrawal Syndrome (PAWS)
This is the part where people quietly give up because they assume sobriety is supposed to feel better by now. Heavy fentanyl use is associated with a protracted recovery period of persistent anxiety, sleep disruption, depressed mood, and cognitive fog lasting weeks to months after acute withdrawal resolves.
Our clinical team addresses PAWS as a treatment priority rather than as an afterthought, because the months of post-acute symptoms are the window when most return-to-use events happen. Psychoeducation on the PAWS timeline is part of the curriculum so that clients can interpret the persistent symptoms as a neurobiological phase of recovery rather than as evidence that sobriety is not working. The fog lifts. That is the message we keep coming back to in group.
Elevated Overdose Risk in Early Recovery
This is the conversation we have with every family during admissions, because it matters more than almost any other piece of clinical information. Tolerance drops rapidly after stopping opioids, but cravings do not. The first days and weeks after stopping fentanyl use are among the highest-risk periods for fatal overdose if a return to use occurs. Naloxone access for the client and family, recurrence-prevention planning specific to the early-recovery window, and MAT stabilization where appropriate are all treated as core safety elements of the treatment plan.
Trauma Integration
If you have watched someone die, that does not leave you. Many clients with fentanyl use disorder carry significant trauma, including from witnessing overdose deaths among peers and loved ones, a traumatic experience that has become increasingly common in this population. Trauma-informed care shapes the treatment environment, the language used in group, and the way the clinical team responds to the emotional dimension of the work.
MAT for Fentanyl Use Disorder
Buprenorphine-based MAT is the clinical standard of care for opioid use disorder including fentanyl, and is supported by overwhelming evidence. The transition from active fentanyl use to buprenorphine has clinical nuances because of fentanyl’s potency and short half-life, and the prescribing provider manages the induction protocol carefully.
Roanoke Refuge prescribes FDA-approved MAT medications on-site as part of PHP and IOP, with the medication and therapy integrated as one treatment plan.
Fentanyl Test Strips and Harm Reduction
Surviving long enough to reach the point of being ready is a legitimate and important clinical goal, even if it feels uncomfortable to say. Fentanyl test strips are inexpensive chemical test strips that detect the presence of fentanyl in a drug supply.
Virginia has expanded access to fentanyl test strips as a public health harm reduction measure. We provide education on test strip availability and use to clients and family members. The information is shared as a harm-reduction strategy for the clinical reality that some people will continue using before they are ready to stop.
Our Clinical Approach to Fentanyl Use Disorder
Here is what the work itself looks like once you have stabilized through detox or MAT initiation. Treatment for fentanyl use disorder at Roanoke Refuge follows the same evidence-based framework as opioid use disorder broadly, calibrated to the substance-specific clinical realities described above. A treatment plan pulls from the following.
- MAT prescribed on-site — Buprenorphine (Suboxone, Subutex, Sublocade, Brixadi) and naltrexone (oral and Vivitrol) are prescribed and managed directly by our medical team as part of treatment.
- Cognitive Behavioral Therapy — Targeting fentanyl-specific triggers, cognitive distortions about overdose risk, and recurrence-prevention skills.
- Dialectical Behavior Therapy skills — Distress tolerance for the high-intensity emotional moments that often precede return to use.
- Motivational Interviewing — Strengthening the client’s own reasons for change during the early ambivalent phase.
- Trauma-informed care — Holding the trauma that often accompanies fentanyl use disorder, including witnessed overdose deaths.
- PAWS management — Psychoeducation and clinical support across the protracted post-acute withdrawal window.
- Recurrence-prevention planning — Specific to the early-recovery overdose risk and the social patterns that surrounded active use.
- Peer recovery support — Peer specialists with lived experience of opioid recovery.
- Family therapy: The Family Program structures the work alongside parents, spouses, and adult children.
Dual Diagnosis and Fentanyl Use Disorder
Co-occurring post-traumatic stress disorder, depression, anxiety, and chronic pain are common in clients with fentanyl use disorder. Treating the substance use without treating the underlying mental health condition is like treating the smoke while leaving the fire burning. Our integrated dual diagnosis program addresses both in the same setting and by the same clinical team.
Co-occurring mental health conditions are the rule, not the exception, with fentanyl use disorder. The most common combinations we see are fentanyl use with post-traumatic stress disorder (especially in veterans from the Salem VA Medical Center referral channel), with major depressive disorder, and with anxiety disorders. The substance often started as self-medication for one of these underlying conditions and then became the dominant clinical problem in its own right. Treating only the substance use while leaving the trauma or depression untreated reliably produces relapse — which is why integrated dual-diagnosis treatment is the standard of care.
Fentanyl complicates MAT induction in ways the older opioids did not. Because fentanyl is highly lipophilic, it accumulates in body tissues and continues releasing into the bloodstream for days after the last use, which can precipitate severe withdrawal when buprenorphine is started too soon. Our medical team uses extended washout protocols and microdosing approaches to navigate this, with close monitoring and the option to coordinate inpatient stabilization through partner providers when the clinical picture calls for it. The conversation about the right MAT path for each client happens during admissions, before any medication is started.
Local, regional, and accessible.
Treatment for this substance is delivered from our Salem facility at 1630 Braeburn Drive — just off I-81 exit 137. The Roanoke Valley service area covers Roanoke City, Salem, Vinton, and the surrounding counties of Roanoke, Botetourt, and Bedford. The Salem VA Medical Center sits roughly two miles away and serves as a referral partner for veterans transitioning to civilian outpatient care.
The path in is a single phone call. The admissions team walks through fit, level of care, insurance, and what the first week of treatment will actually look like — at no cost and with no clinical commitment until you are ready. Insurance benefits get verified during the same call. Call (540) 900-0353 to start the conversation.